Vanguard Personalized Indexing Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 2,068 shares of RYTM stock, worth $205,703. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,068Holding current value
$205,703% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
254Shares Held
64.4MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$671 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$557 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$553 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$485 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$357 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.54B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...